Paracetamol + Bromhexine + Dextromethorphan + Phenylephrine Dispersible Tablets Manufacturer

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Paracetamol + Bromhexine + Dextromethorphan + Phenylephrine Dispersible Tablets are respiratory care formulations used for cough, mucus congestion, throat irritation, fever, and blocked nose associated with upper respiratory tract infections.

The formulation contains Bromhexine for mucus thinning, Dextromethorphan for cough suppression, Phenylephrine for nasal congestion relief, and Paracetamol for reduction of fever and body discomfort during respiratory infections and seasonal flu conditions.

Genliva Wellness LLP develops these medicines as a Cough and Congestion Dispersible Tablets Manufacturer, offering respiratory combination formulations for pharmaceutical export supply, OTC cold care product portfolios, third party manufacturing, and global respiratory healthcare distribution.

Paracetamol + Bromhexine + Dextromethorphan + Phenylephrine Dispersible Tablets are formulated for cough and respiratory congestion management.

Multi-action respiratory dispersible formulation
Frequently utilized in cough and cold care
Helps loosen mucus from respiratory passages
Supports cough suppression and nasal relief
Manufactured under stringent pharmaceutical standards
Intended for respiratory discomfort management

This formulation is prescribed in cough and congestion management therapies.

Treatment of cough and throat irritation
Management of mucus and chest congestion
Administered in seasonal flu conditions
Utilized in nasal blockage management
Helps reduce respiratory discomfort symptoms
Frequently selected in cold and cough therapies

Paracetamol + Bromhexine + Dextromethorphan + Phenylephrine Dispersible Tablets deliver respiratory and cough symptom relief.

Valuable in mucus congestion management
Frequently preferred in productive cough treatment
Fast dissolving dispersible dosage support
Useful in seasonal respiratory discomfort
Combines mucolytic and cough suppressant activity
Maintains effective respiratory care performance